UCHealth partnered with BioIntelliSense in 2020 to use its BioSticker device on patients with chronic conditions, such as diabetes, heart failure and hypertension. The company’s body sensor can continuously monitor patient vital signs from home and deliver insights to clinicians.
“BioIntelliSense represents the future of healthcare; medical grade monitoring with best-in-class data science feeding life-changing AI and prescriptive analytics at reasonable cost,” Richard Zane, MD, chief innovation officer at UCHealth, said in the July 28 news release. “As one of BioIntelliSense’s earliest partners, UCHealth already is utilizing this technology to remotely observe patients for detection of deterioration, allowing for early intervention to improve outcomes.”
Philips, 7wireTechnology Partners and Pendrell Corp. were among investors in the fundraising round.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
